Details of the Drug Reposition

General Information of This Drug (ID: DMFCPG0)

Drug Name	CAR-T cells targeting GD2 DMFCPG0
Drug Type	CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Lung cancer	DISCM4YA	2C25.0	Phase 1/2	[1]
------------------------------------------------------------------------------------

1 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Glioblastoma multiforme	DISK8246	2A00.0	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03356808) Antigen-specific T Cells Against Lung Cancer
2	ClinicalTrials.gov (NCT03170141) Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme